Rising Stars in Cardiology Conference 2026

Saturday May 30th, 2026 

register now
RSO2025Banner

Conference Objectives

The 2026 Rising Stars in Cardiology  Conference will serve a foundational role in helping early-in-practice cardiologists gain meaningful insight into patient and disease management. This event is geared towards the early-in-practice clinician and will include didactic lectures, complex case discussions, and panel Q&A sessions.

Scientific Steering Committee

Dr. Beth Abramson

Biography

Dr. Kevin Bainey

Biography

Dr. Guillaume Marquis-Gravel

Biography

Register Today: Spots Are Limited!

Only 50 spots, including limited travel grants, are available for this one-of-a-kind conference and we encourage you to register early.

If you are able to join us, kindly RSVP by registering to the conference using the link below. Registrations will close on January 15th, 2026, or when the conference reaches capacity. As space is limited, we encourage you to RSVP at your earliest convenience if you plan to attend.

register now

Conference Agenda

Time

Topic

Speaker

8:45 AM–9:00 AM

Welcome & Opening Remarks

2026 Scientific Steering Committee

9:00 AM- 9:30 AM

Keynote: Inflammation and Where We Stand Now

Paul Ridker

9:30 AM–9:50 AM

Anti-platelet therapy in 2026: Guidelines and Beyond

TBD

9:50 AM- 10:10 AM

Chronic Coronary Syndromes Using Lipid Lowering Therapies in 2026

George Thanassoulis

10:10 AM-10:30 AM

Chronic Coronary Syndromes: Addressing Residual Risk

Kim Connelly

10:30 AM–10:50 AM

Networking Break

ALL

10:50 AM–11:20 AM

Diabetes for the Cardiologist: What You Need to Know

Alice Cheng

11:20 AM–11:50 AM

Vascular Prevention Panel Discussion

Panelists TBD

11:50 PM–1:15 PM

LUNCH

ALL

1:15 PM–1:45 PM

PAF on Holter Monitoring: What does it mean and what do we do?

TBD

1:45 PM–2:15 PM

Atrial fibrillation: Rate vs Rhythm in Treating the Patient in Your Office

Jason Andrade

2:15 PM–2:45 PM

Arrythmia Panel Discussion

Panelists TBD

2:45 PM–3:05 PM

Networking Break

ALL

3:05 PM–3:35 PM

Approach to HFpEF: Diagnostic Testing and Management

Eileen O’Meara

3:35 PM- 4:05 PM

Heart Failure Management and Valvular Intervention

Rob Boone

4:05 PM- 4:35 PM

The Role of Revascularization for HFrEF

Peter Liu

4:35 PM- 5:00 PM

Heart Failure Panel Discussion

Panelists TBD

5:00 PM- 5:15 PM

Closing Remarks & Adjournment

2026 Scientific Steering Committee

Our Sponsors
Silver Sponsor
Novo
Bronze Sponsor
Novartis-Emblem

Subscribe To Canadian Cardiology Today

Canadian Cardiology Today provides a forum for the clinical community to share real-world experience and the latest best practices in the treatment and management of cardiac disease.

The journal is published thrice yearly in English and is circulated to over 750 cardiologists across Canada. It features peer-reviewed articles that present robust clinical perspectives and practical insights into disease management.

CCT
Subscribe
Archives
About Catalytic Health

Founded in 2009, Catalytic Health is one of Canada’s largest medical education agencies and reaches over 50,000 Canadian clinicians a year with its educational programs, services and platforms. Catalytic Health is also the largest independent medical publisher in Canada, one of the largest scientific conference providers, and a leader in innovative events and services for the Life Sciences industry. Learn more about Catalytic Health.

Contact Us
Linkedin Envelope Link

© 2026 All Rights Reserved.

CloseMenu

Dr. Beth Abramson MD is the Paul Albrechtsen Professor in Cardiac Prevention and Women’s Health in the Division of Cardiology at St. Michael’s Hospital, University of Toronto. She is also an Associate Professor of Medicine at the University of Toronto.

She enjoys educating the public on heart health and is a national spokesperson for the Heart and Stroke Foundation. Her book, Heart Health for Canadians, published in 2013, aims to help people prevent and understand heart disease. In 2015, she was awarded the prestigious Harold N. Segal award of Merit, in recognition of her many contributions to preventing heart disease amongst Canadians. She is a member of the American Society of Preventive Cardiology Women’s working group, and has co-chaired the American College of Cardiology’s Hypertension working group. In 2021, she was invited to become a member of the American College of Cardiology Prevention Council.

In addition, Dr. Abramson is a founding member and inaugural Chair (2018-2020) of the Canadian Women’s Heart Health Alliance Education Working Group, which has created an electronic course and toolkit on Women and Heart Disease for MDs. Dr. Abramson’s has also been involved in the North American Menopause Societys’ (NAMS) awareness efforts.

She currently directs a fellowship in Preventive Cardiology at the University of Toronto and has recently established an academic Cardiometabolic Clinic at St. Michael’s Hospital to close care gaps. Dr. Abramson also works out of the Toronto Cardiac Clinic.

CloseMenu

Interventional cardiologist Kevin Bainey is a graduate of the University of Alberta’s medical school. After completing his core internal medicine and clinical cardiology residencies in Edmonton (University of Alberta), Dr. Bainey pursued an interventional cardiology fellowship at Harvard University, Boston and subsequently became a clinical scholar in interventional cardiology at McMaster University, Hamilton.   He was the recipient of numerous awards during his undergraduate and residency medical education. Dr. Bainey also completed a Master of Science degree in health research methodology at McMaster. In 2011, he was recruited to the University of Alberta’s Division of Cardiology and works at the Mazankowski Alberta Heart Institute.

Dr. Bainey is faculty at the VIGOUR Centre in the Katz Group for Pharmacy and Health Research. He leads and collaborates on numerous clinical trials for therapies for heart conditions. Among his research interests are reperfusion Injury in ST-elevation myocardial infarction, ethnic-based clinical outcomes focusing primarily on South Asians with coronary artery disease, myocardial infarction with non-obstructive coronary arteries and heart attacks in women. His research, funded by provincial and national agencies including Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research and Alberta Health Services Quality Innovation Fund, has been published widely in peer-reviewed journals. These include American Journal of Cardiology, American Heart Journal, International Journal of Cardiology, Circulation, Cardiovascular Interventions, Journal of American College of Cardiology, New England Journal of Medicine, and Canadian Journal of Cardiology.

CloseMenu

Dr. Guillaume Marquis-Gravel is an interventional cardiologist at the Montreal Heart Institute, and an associate professor at Université de Montréal since 2020. He is a Junior 2 clinical research scholar of the Fonds de la Recherche du Québec – Santé (FRQS). He completed his medical training (M.D.), a Masters in Biomedical Sciences (M.Sc., with Honors), a residency in internal medicine, and a residency in adult cardiology (with Honors) at the Université de Montréal. He then completed a 1-year clinical fellowship in interventional cardiology at Duke University (Durham, NC, United States), followed by a 2-year clinical research fellowship at the Duke Clinical Research Institute. 

He is the primary author or co-author of more than 130 peer-reviewed publications, including in the New England Journal of Medicine, JAMA Cardiology, the Journal of the American College of Cardiology, and Circulation, and of 5 book chapters. He is an associate editor of the Canadian Journal of Cardiology. His main research interests revolve around the antithrombotic management of acute and chronic coronary artery disease, prevention of contrast-induced nephropathy after PCI, and development of innovative clinical trial methods. He is the principal investigator of research projects funded by the Canadian Institutes of Health Research (CIHR), the Heart & Stroke Foundation, and the Canadian Heart Function Alliance. He is the co-chair of the 2023 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy.